Malawi’s preparations to develop an integrated HIV/TB concept note required under the new funding model have included the election on 12 February of two new members to its country coordination mechanism (CCM) with roots in the TB community.
Integration of TB and HIV programs in high burden countries both necessary and beneficial, experts say
Forty-one countries will from 2014 be required by the Global Fund to submit joint TB-HIV concept notes under the new funding model in what experts in both fields consider to be necessary and beneficial but also challenging to implement.
With a budget of $65 million annually, the Local Fund Agents represent a significant and critical element in the Global Fund’s architecture and reflects about 20 percent of its total operating budget. Despite this, there has been little reflection or review of this piece of the model. One of the last reviews of the LFA system was commissioned by the Fund in 2006, and published online in 2007.
by Kate Macintyre
A mere $28billion later and the Global Fund’s dedication to country ownership as a guiding principle is still intact, bolstered, reinforced, reinvented or reemphasized at almost every opportunity.
At its meeting on 8–9 October, the Strategy, Investment and Impact Committee (SIIC) made decisions in four areas related to the new funding model (NFM): awarding of incentive funding, managing unfunded quality demand, health systems strengthening and TB/HIV collaboration. This article provides details.
On 7–8 November 2013, the Global Fund Board held its 30th meeting in Geneva, Switzerland. GFO was present, with observer status. The main decisions made at the meeting, in chronological order, were as follows. (For precise wording of what the Board agreed, see the decision points document that has been posted here.
The Global Fund is expecting a rush of applications in 2014 for the full roll-out of the new funding model. In his report for the Board meeting held on 7–8 November, Executive Director Mark Dybul said that in 2014 the Secretariat expects to sign grants for about half of the disease components for the entire 2014–2016 allocation period.
As of 19 September 2013, $118 million in losses had been identified by the Office of the Inspector General (OIG), of which $23.8 million (20%) had been recovered. Written commitments to repay a further $10.4 million had been obtained.
This information was contained in a Losses and Recoveries Report prepared for the Global Fund Board meeting on 7–8 November in Geneva.
The Strategy, Investment and Impact Committee (SIIC) has determined the parameters to be used for the allocations formula for 2014–2016. The SIIC approved indicators for disease burden and ability to pay; the methodology for determining Band 4 allocations; and maximum and minimum shares for apportioning indicative funding. This article provides details.